CAMBRIDGE, Mass. & OSAKA, Japan–(BUSINESS WIRE)–Oct 18, 2016–Takeda Pharmaceutical Company Limited ( TSE: 4502 ) will present data on ADCETRIS ® (brentuximab vedotin) in Hodgkin lymphoma at the 10 th International Symposium on Hodgkin Lymphoma (ISHL …
( read original story …)